Geode Capital Management, LLC Editas Medicine, Inc. Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,887,696 shares of EDIT stock, worth $2.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,887,696
Previous 1,965,822 3.97%
Holding current value
$2.47 Million
Previous $9.18 Million 29.88%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$3.39 - $5.96 $264,847 - $465,630
-78,126 Reduced 3.97%
1,887,696 $6.44 Million
Q2 2024

Aug 09, 2024
BUY
$4.67 - $7.28 $98,345 - $153,309
21,059 Added 1.08%
1,965,822 $9.18 Million
Q1 2024

May 13, 2024
BUY
$7.03 - $11.07 $302,486 - $476,319
43,028 Added 2.26%
1,944,763 $14.4 Million
Q4 2023

Feb 13, 2024
BUY
$6.25 - $11.11 $585,975 - $1.04 Million
93,756 Added 5.19%
1,901,735 $19.3 Million
Q3 2023

Nov 13, 2023
BUY
$6.92 - $9.31 $2.18 Million - $2.93 Million
315,156 Added 21.11%
1,807,979 $14.1 Million
Q2 2023

Aug 11, 2023
BUY
$6.36 - $11.47 $264,378 - $476,796
41,569 Added 2.86%
1,492,823 $12.3 Million
Q1 2023

May 15, 2023
BUY
$7.03 - $11.53 $503,144 - $825,213
71,571 Added 5.19%
1,451,254 $10.5 Million
Q4 2022

Feb 13, 2023
BUY
$8.32 - $13.21 $1.02 Million - $1.63 Million
123,163 Added 9.8%
1,379,683 $12.2 Million
Q3 2022

Nov 14, 2022
BUY
$12.16 - $19.42 $363,462 - $580,463
29,890 Added 2.44%
1,256,520 $15.4 Million
Q2 2022

Aug 12, 2022
BUY
$9.99 - $21.35 $901,937 - $1.93 Million
90,284 Added 7.95%
1,226,630 $14.5 Million
Q1 2022

May 13, 2022
SELL
$14.08 - $27.63 $1.18 Million - $2.32 Million
-84,025 Reduced 6.89%
1,136,346 $21.6 Million
Q4 2021

Feb 11, 2022
BUY
$26.55 - $40.57 $671,263 - $1.03 Million
25,283 Added 2.12%
1,220,371 $32.4 Million
Q3 2021

Nov 12, 2021
SELL
$39.27 - $72.94 $399,886 - $742,748
-10,183 Reduced 0.84%
1,195,088 $49.1 Million
Q2 2021

Aug 13, 2021
BUY
$31.29 - $56.64 $1.62 Million - $2.94 Million
51,906 Added 4.5%
1,205,271 $68.3 Million
Q1 2021

May 12, 2021
BUY
$39.71 - $90.58 $7.47 Million - $17 Million
188,192 Added 19.5%
1,153,365 $48.4 Million
Q4 2020

Feb 12, 2021
BUY
$27.07 - $84.35 $919,865 - $2.87 Million
33,981 Added 3.65%
965,173 $67.7 Million
Q3 2020

Nov 13, 2020
BUY
$28.06 - $37.16 $1.16 Million - $1.54 Million
41,513 Added 4.67%
931,192 $26.1 Million
Q2 2020

Aug 13, 2020
BUY
$18.5 - $34.34 $1.94 Million - $3.61 Million
105,111 Added 13.4%
889,679 $26.3 Million
Q1 2020

May 14, 2020
BUY
$14.88 - $32.78 $1.11 Million - $2.45 Million
74,818 Added 10.54%
784,568 $15.6 Million
Q4 2019

Feb 13, 2020
BUY
$19.49 - $32.63 $1.32 Million - $2.2 Million
67,536 Added 10.52%
709,750 $21 Million
Q3 2019

Nov 12, 2019
BUY
$22.49 - $26.81 $827,901 - $986,929
36,812 Added 6.08%
642,214 $14.6 Million
Q2 2019

Aug 14, 2019
BUY
$20.48 - $27.76 $1.27 Million - $1.72 Million
61,804 Added 11.37%
605,402 $15 Million
Q1 2019

May 14, 2019
BUY
$19.43 - $26.41 $747,724 - $1.02 Million
38,483 Added 7.62%
543,598 $13.3 Million
Q4 2018

Feb 13, 2019
BUY
$18.19 - $31.79 $933,056 - $1.63 Million
51,295 Added 11.3%
505,115 $11.5 Million
Q3 2018

Nov 13, 2018
BUY
$27.65 - $38.39 $196,453 - $272,760
7,105 Added 1.59%
453,820 $14.4 Million
Q2 2018

Aug 14, 2018
BUY
$31.4 - $41.01 $2.82 Million - $3.68 Million
89,734 Added 25.14%
446,715 $16 Million
Q1 2018

May 15, 2018
BUY
$29.84 - $44.08 $2 Million - $2.96 Million
67,126 Added 23.16%
356,981 $11.8 Million
Q4 2017

Feb 13, 2018
BUY
$21.89 - $31.34 $1.12 Million - $1.6 Million
51,059 Added 21.38%
289,855 $8.91 Million
Q3 2017

Nov 14, 2017
SELL
$15.81 - $24.01 $731,734 - $1.11 Million
-46,283 Reduced 16.24%
238,796 $5.73 Million
Q2 2017

Aug 14, 2017
BUY
N/A
285,079
285,079 $4.78 Million

Others Institutions Holding EDIT

# of Institutions
248
Shares Held
57M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $90M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email